FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

332347007: Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3693212013 Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3693213015 Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution est un(e) (attribut) Erythromycin and zinc acetate only product in cutaneous dose form true Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has basis of strength substance (attribute) Erythromycin (substance) true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has precise active ingredient Erythromycin (substance) true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has basis of strength substance (attribute) Zinc acetate (substance) true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has precise active ingredient Zinc acetate (substance) true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution est un(e) (attribut) Product containing erythromycin in topical dosage form (medicinal product form) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a pour principe actif (attribut) Erythromycin (substance) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution est un(e) (attribut) Product containing erythromycin and zinc acetate (medicinal product) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a pour principe actif (attribut) Zinc acetate (substance) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a pour principe actif (attribut) Zinc false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a pour principe actif (attribut) Bactericide false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a une forme pharmaceutique (attribut) Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a une forme pharmaceutique (attribut) Solution false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution a une forme pharmaceutique (attribut) Cutaneous solution true Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution est un(e) (attribut) Product containing zinc acetate in topical dosage form (medicinal product form) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength denominator value un false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength denominator value un false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength denominator unit Milliliter (qualifier value) true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Count of base of active ingredient deux false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength denominator unit Milliliter (qualifier value) true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has basis of strength substance (attribute) Erythromycin (substance) false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has precise active ingredient Zinc acetate (substance) false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength numerator value (attribute) douze false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has basis of strength substance (attribute) Zinc acetate (substance) false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has precise active ingredient Erythromycin (substance) false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength numerator value (attribute) 40 (qualifier value) false Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada French language reference set (foundation metadata concept)

Back to Start